Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Breast Neoplasms; Breast Neoplasms, Male | Phase 1/Phase 2 | ClinicalTrials |
| Breast Neoplasms | Phase 1 | ClinicalTrials |
| Breast Neoplasms; Lung Neoplasms | Phase 1 | ClinicalTrials |
| Breast Neoplasms; Lung Neoplasms | Phase 1 | ClinicalTrials |
| Breast Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Breast Neoplasms; Breast Neoplasms, Male | Phase 1/Phase 2 | ClinicalTrials |
| Breast Neoplasms; Breast Neoplasms, Male | Phase 1 | ClinicalTrials |
| Breast Neoplasms; Breast Neoplasms, Male | Phase 2 | ClinicalTrials |
| Carcinoma, Ovarian Epithelial; Ovarian Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Breast Neoplasms | Early Phase 1 | ClinicalTrials |
| Breast Neoplasms; Breast Neoplasms, Male | Phase 1 | ClinicalTrials |
| Breast Neoplasms; Breast Neoplasms, Male | Phase 2 | ClinicalTrials |
CONTENTS